Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS AND VIEWS

Brain inflammatory cascade controlled by gut-derived molecules

Metabolite molecules produced by the gut’s microbes activate immune cells in the brain called microglia, which signal to astrocyte cells to mediate responses to inflammation in the central nervous system.
  1. Hartmut Wekerle

    1. Hartmut Wekerle is at the Max Planck Institute of Neurobiology, D-82152 Martinsried, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Some immunologists regard the central nervous system (CNS) as a no-man’s-land, avoided by immune cells and therefore uninteresting. But, in fact, the CNS has a vigorous immune potential that remains dormant in normal conditions but is awakened after injury. The switch that controls the brain’s immune microenvironment involves non-neuronal cells called glia — not only microglia, which are sometimes called the immune cells of the CNS, but also multifunctional cells called astrocytes1. In a paper in Nature, Rothhammer et al.2 describe how these two glial cell types communicate on a molecular level to influence inflammation in the CNS, and show that this interaction is controlled remotely by microbes that inhabit the gut.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Nature 557, 642-643 (2018)

doi: https://doi.org/10.1038/d41586-018-05113-0

References

  1. Salter, M. W. & Stevens, B. Nature Med. 23, 1018–1027 (2017).

    PubMed  Article  Google Scholar 

  2. Rothhammer, V. et al. Nature 557, 724–728 (2018).

    Article  Google Scholar 

  3. Quintana, F. J. et al. Nature 453, 65–71 (2008).

    PubMed  Article  Google Scholar 

  4. Veldhoen, M. et al. Nature 453, 106–109 (2008).

    PubMed  Article  Google Scholar 

  5. Okey, A. B., Riddick, D. S. & Harper, P. A. Trends Pharmacol. Sci. 15, 226–232 (1994).

    PubMed  Article  Google Scholar 

  6. Rothhammer, V. et al. Nature Med. 22, 586–597 (2016).

    PubMed  Article  Google Scholar 

  7. Liddelow, S. A. et al. Nature 541, 481–487 (2017).

    PubMed  Article  Google Scholar 

  8. Stockinger, B., Di Meglio, P., Gialitakis, M. & Duarte, J. H. Annu. Rev. Immunol. 32, 403–432 (2014).

    PubMed  Article  Google Scholar 

  9. Veldhoen, M. & Brucklacher-Waldert, V. Nature Rev. Immunol. 12, 696–708 (2012).

    PubMed  Article  Google Scholar 

  10. Lassmann, H. & Wekerle, H. in McAlpine’s Multiple Sclerosis 4th edn (eds Compston, A. et al.) 557–600 (Churchill Livingstone, 2006).

    Google Scholar 

  11. Sofroniew, M. V. Neuroscientist 20, 160–172 (2014).

    PubMed  Article  Google Scholar 

  12. Monaco, M. C. G. & Major, E. O. Front. Immunol. 6, 159 (2015).

    PubMed  Article  Google Scholar 

  13. Li, Q. & Barres, B. A. Nature Rev. Immunol. 18, 225–242 (2018).

    PubMed  Article  Google Scholar 

  14. Neumann, H. Glia 36, 191–199 (2001).

    PubMed  Article  Google Scholar 

  15. Sampson, T. R. & Mazmanian, S. K. Cell Host Microbe 17, 565–576 (2015).

    PubMed  Article  Google Scholar 

  16. Erny, D. et al. Nature Neurosci. 18, 965–977 (2015).

    PubMed  Article  Google Scholar 

  17. Riemann-Lorenz, K. et al. PLoS ONE 11, e0165246 (2016).

    PubMed  Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links